Latest / Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology
Anti-Amyloid Antibodies for Alzheimer’s Disease: Efficacy and Safety
This umbrella review evaluates the clinical efficacy and safety of two recently approved anti-amyloid antibodies, lecanemab and donanemab, for treating early-stage Alzheimer’s disease. By synthesizing data from eleven high-quality systematic reviews and meta-analyses, the authors conclude that these drugs successfully reduce brain amyloid burden and provide a statistically significant slowing of cognitive decline. However, the text highlights a critical concern: the observed cognitive benefits often fall below established clinically meaningful thresholds, suggesting that patients might not…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.